S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › PDN › Research report
← PDN page
XStocksXray
Market X-Ray report · 20 October 2026

Paladin Energy Ltd (PDN)

Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026

Key indicators

Last closeAUD 7.220
52-week range6.820 – 15.100
Return, 1 month / 3 months−28.9% / −29.1%
Return, 1 year / 3 years−13.7% / −22.4%
TrendBelow its 200-day average
RSI (14)27
Volatility (1 year)68.2%
Worst drawdown (1 year)-52.5%
Average daily value traded30.16M AUD
Dividend yield–

Market X-Ray price-based

51/ 100 · High confidence · ahead of 51% of stocks on this exchange
Trend35
Momentum38
Stability (higher is calmer)54
Liquidity96
Income–

Five-year price chart navy: price · brown: 200-day average

3.157.0210.8914.7618.632021-102023-012024-042025-072026-10

About the company

Paladin Energy is a uranium company based in Perth, Western Australia. It produces uranium concentrate, known as yellowcake, from its mine in Namibia and supplies it to utilities and other customers in the nuclear fuel market. The company's activities cover mining, processing and the sale of uranium oxide, and its operations are centred on its African project while its corporate and technical functions are managed from Australia.

Paladin Energy Ltd trades under the code PDN on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Paladin Energy Ltd (PDN) trades on the Australian Securities Exchange in Australia. It last closed at AUD 7.220 on 20 October 2026.

Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 883 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 13.7% and over the last three months it fell 29.1%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Paladin Energy Ltd (PDN)

The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange

Lens and metricValueScoreReading
Trend35 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-34.3%
From 52-week high-50.3%
Momentum38 · WeakLagging most stocks on this exchange.
3-month return-29.1%
6-month return-42.7%
12-month return, skipping the last month21.4%
Stability (higher is calmer)54 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)68.2%
Worst drawdown, 1 year (smaller is calmer)-52.5%
Liquidity96 · StrongTrades actively.
Average daily value traded30.16M AUD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.

Returns

1 week−10.1%
1 month−28.9%
3 months−29.1%
6 months−42.7%
1 year−13.7%
3 years−22.4%
5 years−24.0%

Signals

50-day / 200-day average9.995 / 10.984
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.462

Technical summary

DailyBearish4 bullish · 0 neutral · 12 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish1 bullish · 1 neutral · 6 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026